Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CALIPER LIFE SCIENCES INC (CALP)
|
Add to portfolio |
|
|
|
| Price: |
$10.47
| | Metrics |
| OS: |
55.2
|
M
| |
-8
|
% ROE
|
| Market cap: |
$578
|
M
| |
32
|
% ROIC
|
|
Net cash:
|
$47.3
|
M
| |
$0.86
|
per share
|
|
EV:
|
$531
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$16.2
|
M
| |
32.7
|
x EV/EBITDA
|
|
EBIT
|
$7.0
|
M
| |
75.6
|
x EV/EBIT
|
| EPS |
($0.15)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 |
| Revenues | 123.7 | 130.4 | 134.1 | 140.7 | 107.9 | 87.0 | 80.1 | 49.4 |
| Revenue growth | -5.1% | -2.7% | -4.7% | 30.4% | 24.0% | 8.6% | 62.2% | 91.3% |
| Cost of goods sold | 59.5 | 72.5 | 78.4 | 74.6 | 60.6 | 48.4 | 45.2 | 26.0 |
| Gross profit | 64.2 | 57.9 | 55.7 | 66.1 | 47.3 | 38.6 | 34.9 | 23.4 |
| Gross margin | 51.9% | 44.4% | 41.5% | 47.0% | 43.8% | 44.3% | 43.6% | 47.4% |
| Selling, general and administrative | 45.3 | 44.9 | 49.0 | 55.0 | 43.6 | 32.3 | 34.4 | 27.3 |
| Research and development | 18.0 | 17.9 | 19.9 | 24.8 | 24.6 | 17.7 | 23.2 | 33.7 |
| EBITA | 12.3 | 0.1 | -11.1 | -13.7 | -20.9 | -11.5 | -22.7 | -38.6 |
| EBITA margin | 9.9% | 0.1% | -8.3% | -9.7% | -19.4% | -13.2% | -28.4% | -78.0% |
| Amortization of intangibles | 4.8 | 6.6 | 8.3 | 10.1 | 8.8 | 4.1 | 3.8 | 2.8 |
| EBIT | 7.4 | -6.5 | -19.4 | -23.8 | -29.7 | -15.6 | -26.5 | -41.3 |
| EBIT margin | 6.0% | -5.0% | -14.5% | -16.9% | -27.6% | -17.9% | -33.1% | -83.6% |
| Pre-tax income | 4.6 | -8.0 | -67.7 | -23.8 | -29.0 | -14.3 | -31.2 | -49.3 |
| Income taxes | 0.4 | 0.2 | 0.6 | 0.3 | -0.1 | 0.1 | 0.4 | 0.2 |
| Tax rate | 8.0% | | | | 0.4% | | | |
| Net income | 4.3 | -8.2 | -68.3 | -24.1 | -28.9 | -14.5 | -31.6 | -49.5 |
| Net margin | 3.5% | -6.3% | -50.9% | -17.1% | -26.8% | -16.6% | -39.4% | -100.2% |
| |
| Diluted EPS | $0.08 | ($0.17) | ($1.42) | ($0.51) | ($0.75) | ($0.46) | ($1.08) | ($1.88) |
| Shares outstanding (diluted) | 52.4 | 48.9 | 48.1 | 47.3 | 38.7 | 31.3 | 29.3 | 26.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|